Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	SMG1 NTRK1 DGKA CDC42BPB RYK PIK3R4 JAK1 TGFBR3 TTBK2 FAM20C NEK5 PI4KB PRKCG EEF2K PRKDC HCK	9.61e-05	709	151	16	GO:0016773
GeneOntologyMolecularFunction	low voltage-gated calcium channel activity	CACNA1H CACNA1G	1.70e-04	3	151	2	GO:0008332
GeneOntologyMolecularFunction	protein kinase activity	SMG1 NTRK1 CDC42BPB RYK PIK3R4 JAK1 TGFBR3 TTBK2 FAM20C NEK5 PRKCG EEF2K PRKDC HCK	1.90e-04	600	151	14	GO:0004672
GeneOntologyMolecularFunction	kinase activity	SMG1 NTRK1 DGKA CDC42BPB RYK PIK3R4 JAK1 TGFBR3 TTBK2 FAM20C NEK5 PI4KB PRKCG EEF2K PRKDC HCK	2.25e-04	764	151	16	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	SMG1 NTRK1 GNPTAB DGKA CDC42BPB RYK PIK3R4 JAK1 TGFBR3 TTBK2 FAM20C PIGF NEK5 PI4KB PRKCG EEF2K PRKDC HCK	2.64e-04	938	151	18	GO:0016772
GeneOntologyBiologicalProcess	glycerolipid biosynthetic process	PITPNM2 SMG1 DGKA GPAM PITPNM1 PIK3R4 LPIN3 MTMR6 PIGF MTMR14 PI4KB LPIN2	5.93e-07	268	149	12	GO:0045017
GeneOntologyBiologicalProcess	glycerolipid metabolic process	PITPNM2 SMG1 GAL3ST1 DGKA GPAM APOB PITPNM1 PIK3R4 LPIN3 MTMR6 PIGF MTMR14 PI4KB LPIN2	2.91e-06	429	149	14	GO:0046486
GeneOntologyBiologicalProcess	glycerophospholipid biosynthetic process	PITPNM2 SMG1 DGKA GPAM PITPNM1 PIK3R4 MTMR6 PIGF MTMR14 PI4KB	4.13e-06	217	149	10	GO:0046474
GeneOntologyBiologicalProcess	phosphatidylinositol biosynthetic process	PITPNM2 SMG1 PITPNM1 PIK3R4 MTMR6 PIGF MTMR14 PI4KB	5.31e-06	132	149	8	GO:0006661
GeneOntologyBiologicalProcess	lipid biosynthetic process	PITPNM2 SMG1 ABCC1 GAL3ST1 DGKA GPAM APOB B4GALT5 PITPNM1 PIK3R4 LPIN3 MTMR6 SCAP PIGF MTMR14 PI4KB LPIN2 CACNA1H	2.41e-05	813	149	18	GO:0008610
GeneOntologyBiologicalProcess	phospholipid biosynthetic process	PITPNM2 SMG1 DGKA GPAM PITPNM1 PIK3R4 MTMR6 PIGF MTMR14 PI4KB	2.60e-05	268	149	10	GO:0008654
GeneOntologyBiologicalProcess	phosphatidylinositol metabolic process	PITPNM2 SMG1 PITPNM1 PIK3R4 MTMR6 PIGF MTMR14 PI4KB	3.35e-05	170	149	8	GO:0046488
GeneOntologyBiologicalProcess	retinal pigment epithelium development	TMEM135 TBC1D32 IHH	4.27e-05	10	149	3	GO:0003406
GeneOntologyBiologicalProcess	regulation of organelle organization	SMG1 NCAPD3 CIB1 VPS13C TMEM135 CUL9 GRID2 CEP192 STIL ECT2 MAD2L1BP SLC2A4 FZD9 TTBK2 LMAN1 ALMS1 SIPA1L1 RECQL4 LIMCH1 TBC1D21 TASOR CDH5 HCK	9.55e-05	1342	149	23	GO:0033043
GeneOntologyBiologicalProcess	glycerophospholipid metabolic process	PITPNM2 SMG1 DGKA GPAM PITPNM1 PIK3R4 MTMR6 PIGF MTMR14 PI4KB	1.14e-04	320	149	10	GO:0006650
GeneOntologyBiologicalProcess	response to peptide hormone	VPS13C GPAM STAT1 SLC2A4 LPIN3 JAK1 TGFBR3 FAT1 SCAP ZFP36L1 LPIN2 EEF2K PRKDC	1.28e-04	530	149	13	GO:0043434
GeneOntologyBiologicalProcess	serine import into mitochondrion	SFXN3 SFXN2	1.55e-04	3	149	2	GO:0140300
GeneOntologyBiologicalProcess	response to nickel cation	LCT CACNA1G	1.55e-04	3	149	2	GO:0010045
GeneOntologyBiologicalProcess	intraciliary retrograde transport	DYNC2H1 TTC21A IFT122	1.58e-04	15	149	3	GO:0035721
GeneOntologyBiologicalProcess	spermatid differentiation	CIB1 FSCN3 TTC21A YTHDC2 VPS54 MFSD14A ALMS1 GARIN1B TBC1D21	1.65e-04	272	149	9	GO:0048515
GeneOntologyBiologicalProcess	response to insulin	VPS13C GPAM STAT1 SLC2A4 LPIN3 SCAP ZFP36L1 LPIN2 EEF2K PRKDC	1.96e-04	342	149	10	GO:0032868
GeneOntologyBiologicalProcess	non-motile cilium assembly	DYNC2H1 STIL TBC1D32 TTBK2 IFT122	2.54e-04	78	149	5	GO:1905515
Domain	LNS2	PITPNM2 PITPNM1 LPIN3 LPIN2	5.61e-08	6	148	4	IPR013209
Domain	LNS2	PITPNM2 PITPNM1 LPIN3 LPIN2	5.61e-08	6	148	4	SM00775
Domain	LNS2	PITPNM2 PITPNM1 LPIN3 LPIN2	5.61e-08	6	148	4	PF08235
Domain	LNS2/PITP	PITPNM2 PITPNM1 LPIN3 LPIN2	5.61e-08	6	148	4	IPR031315
Domain	SSD	PTCHD3 PTCHD4 SCAP DISP1	2.56e-06	13	148	4	IPR000731
Domain	SSD	PTCHD3 PTCHD4 SCAP DISP1	2.56e-06	13	148	4	PS50156
Domain	ARM-type_fold	PDS5B SMG1 NCAPD3 INTS1 CUL9 APOB TRIP12 PIK3R4 XPO6 LTN1 MROH7 PRKDC	1.69e-05	339	148	12	IPR016024
Domain	HEAT_REPEAT	PDS5B SMG1 NCAPD3 PIK3R4 MROH7 PRKDC	1.93e-05	70	148	6	PS50077
Domain	Ptc/Disp	PTCHD3 PTCHD4 DISP1	3.96e-05	9	148	3	IPR003392
Domain	Patched	PTCHD3 PTCHD4 DISP1	3.96e-05	9	148	3	PF02460
Domain	ARM-like	PDS5B SMG1 NCAPD3 CUL9 TRIP12 PIK3R4 XPO6 LTN1 MROH7 PRKDC	5.97e-05	270	148	10	IPR011989
Domain	Kinase-like_dom	SMG1 NTRK1 CHD9 CDC42BPB RYK PIK3R4 JAK1 TTBK2 NEK5 PI4KB PRKCG EEF2K PRKDC HCK	1.06e-04	542	148	14	IPR011009
Domain	Lipin_N	LPIN3 LPIN2	1.86e-04	3	148	2	IPR007651
Domain	VDCC_T_a1	CACNA1H CACNA1G	1.86e-04	3	148	2	IPR005445
Domain	Lipin_mid	LPIN3 LPIN2	1.86e-04	3	148	2	IPR031703
Domain	Lipin_N	LPIN3 LPIN2	1.86e-04	3	148	2	PF04571
Domain	Lipin_mid	LPIN3 LPIN2	1.86e-04	3	148	2	PF16876
Domain	PI3/4_kinase_CS	SMG1 PI4KB PRKDC	2.07e-04	15	148	3	IPR018936
Domain	-	SMG1 PI4KB PRKDC	2.53e-04	16	148	3	1.10.1070.11
Domain	PI3Kc	SMG1 PI4KB PRKDC	2.53e-04	16	148	3	SM00146
Domain	PI3_PI4_kinase	SMG1 PI4KB PRKDC	3.65e-04	18	148	3	PF00454
Domain	PI3_4_KINASE_1	SMG1 PI4KB PRKDC	3.65e-04	18	148	3	PS00915
Domain	PI3_4_KINASE_2	SMG1 PI4KB PRKDC	3.65e-04	18	148	3	PS00916
Domain	PI3/4_kinase_cat_dom	SMG1 PI4KB PRKDC	3.65e-04	18	148	3	IPR000403
Domain	PI3_4_KINASE_3	SMG1 PI4KB PRKDC	3.65e-04	18	148	3	PS50290
Domain	-	PDS5B NCAPD3 CUL9 TRIP12 PIK3R4 XPO6 MROH7 PRKDC	3.98e-04	222	148	8	1.25.10.10
Domain	IP_trans	PITPNM2 PITPNM1	6.14e-04	5	148	2	PF02121
Domain	Mtc	SFXN3 SFXN2	6.14e-04	5	148	2	PF03820
Domain	FATC	SMG1 PRKDC	6.14e-04	5	148	2	PF02260
Domain	Mtc	SFXN3 SFXN2	6.14e-04	5	148	2	IPR004686
Domain	PI_transfer	PITPNM2 PITPNM1	9.16e-04	6	148	2	IPR001666
Domain	DDHD	PITPNM2 PITPNM1	9.16e-04	6	148	2	PF02862
Domain	DDHD	PITPNM2 PITPNM1	9.16e-04	6	148	2	PS51043
Domain	DDHD_dom	PITPNM2 PITPNM1	9.16e-04	6	148	2	IPR004177
Domain	FAT	SMG1 PRKDC	9.16e-04	6	148	2	PS51189
Domain	FATC	SMG1 PRKDC	9.16e-04	6	148	2	PS51190
Domain	FATC_dom	SMG1 PRKDC	9.16e-04	6	148	2	IPR003152
Domain	PIK_FAT	SMG1 PRKDC	9.16e-04	6	148	2	IPR014009
Domain	DDHD	PITPNM2 PITPNM1	9.16e-04	6	148	2	SM01127
Domain	FATC	SMG1 PRKDC	9.16e-04	6	148	2	SM01343
Domain	Channel_four-helix_dom	KCND3 TMEM266 CACNA1H CACNA1G	1.08e-03	57	148	4	IPR027359
Domain	-	KCND3 TMEM266 CACNA1H CACNA1G	1.08e-03	57	148	4	1.20.120.350
Domain	HECT	HECW1 TRIP12 HERC1	1.24e-03	27	148	3	PF00632
Domain	HECTc	HECW1 TRIP12 HERC1	1.24e-03	27	148	3	SM00119
Domain	HECT_dom	HECW1 TRIP12 HERC1	1.24e-03	27	148	3	IPR000569
Domain	HECT	HECW1 TRIP12 HERC1	1.24e-03	27	148	3	PS50237
Domain	NAD_binding_6	NOX3 DUOX1	1.28e-03	7	148	2	PF08030
Domain	FAD_binding_8	NOX3 DUOX1	1.28e-03	7	148	2	PF08022
Domain	FAD-bd_8	NOX3 DUOX1	1.28e-03	7	148	2	IPR013112
Domain	Fe_red_NAD-bd_6	NOX3 DUOX1	1.28e-03	7	148	2	IPR013121
Domain	-	PITPNM2 PITPNM1 LPIN3 LPIN2	1.66e-03	64	148	4	3.40.50.1000
Domain	R3H	R3HCC1 YTHDC2	2.16e-03	9	148	2	SM00393
Domain	VDCCAlpha1	CACNA1H CACNA1G	2.69e-03	10	148	2	IPR002077
Domain	R3H	R3HCC1 YTHDC2	3.27e-03	11	148	2	PS51061
Domain	R3H	R3HCC1 YTHDC2	3.27e-03	11	148	2	PF01424
Domain	-	R3HCC1 YTHDC2	3.27e-03	11	148	2	3.30.1370.50
Domain	R3H_dom	R3HCC1 YTHDC2	3.27e-03	11	148	2	IPR001374
Domain	HAD-like_dom	PITPNM2 PITPNM1 LPIN3 LPIN2	3.59e-03	79	148	4	IPR023214
Domain	Ferric_reduct	NOX3 DUOX1	3.91e-03	12	148	2	PF01794
Domain	Fe3_Rdtase_TM_dom	NOX3 DUOX1	3.91e-03	12	148	2	IPR013130
Domain	Ser-Thr/Tyr_kinase_cat_dom	NTRK1 RYK JAK1 NEK5 HCK	4.87e-03	138	148	5	IPR001245
Domain	Tyr_kinase_cat_dom	NTRK1 RYK JAK1 HCK	5.28e-03	88	148	4	IPR020635
Domain	TyrKc	NTRK1 RYK JAK1 HCK	5.28e-03	88	148	4	SM00219
Domain	MORN	ANKMY1 RSPH10B	5.33e-03	14	148	2	SM00698
Domain	Cys-rich_flank_reg_C	MXRA5 NTRK1 SLITRK4 LRFN5	5.71e-03	90	148	4	IPR000483
Domain	LRRCT	MXRA5 NTRK1 SLITRK4 LRFN5	5.71e-03	90	148	4	SM00082
Domain	MORN	ANKMY1 RSPH10B	6.12e-03	15	148	2	IPR003409
Domain	MORN	ANKMY1 RSPH10B	6.12e-03	15	148	2	PF02493
Domain	HEAT	NCAPD3 PIK3R4 PRKDC	6.50e-03	48	148	3	PF02985
Domain	CUB	CUBN LRP10 CSMD1	6.88e-03	49	148	3	PF00431
Domain	CUB	CUBN LRP10 CSMD1	7.28e-03	50	148	3	SM00042
Domain	PROTEIN_KINASE_TYR	NTRK1 RYK JAK1 HCK	7.42e-03	97	148	4	PS00109
Domain	Tyr_kinase_AS	NTRK1 RYK JAK1 HCK	7.42e-03	97	148	4	IPR008266
Pathway	REACTOME_PHOSPHOLIPID_METABOLISM	PITPNM2 GPAM PITPNM1 PIK3R4 LPIN3 MTMR6 MTMR14 PI4KB LPIN2	2.41e-05	196	111	9	MM14591
Pathway	REACTOME_PHOSPHOLIPID_METABOLISM	PITPNM2 GPAM PITPNM1 PIK3R4 LPIN3 MTMR6 MTMR14 PI4KB LPIN2	4.29e-05	211	111	9	M649
Pathway	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	GPAM LPIN3 LPIN2	9.93e-05	12	111	3	MM15447
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SMG1 HECW1 GNPTAB ADGRV1 CDC42BPB SCAP ALMS1 XPO6 SIPA1L1 ZBTB40 PCNX1 CACNA1G	4.28e-10	225	154	12	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PITPNM2 SMG1 DENND2A NCAPD3 VPS13C SH3GLB2 SPG11 ADGRV1 SF3B3 PCNX1 CACNA1G KDM7A CRAMP1 IGSF3	1.13e-07	529	154	14	14621295
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DGKA APOB CEP192 CUBN TRIP12 STAT1 MFSD14A ARHGAP5 TTBK2 MTMR6 SCAP SIPA1L1 SFXN3 LTN1 ZBTB40 HERC1 MTO1 COG5 TASOR	3.66e-07	1084	154	19	11544199
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	NCAPD3 CUL9 TRIP12 PIK3R4 JAK1 SIPA1L1 LTN1 RMND1 TASOR	4.83e-07	212	154	9	33853758
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PITPNM2 NUP85 INTS1 CUL9 CEP192 CDC42BPB LPIN3 FAM20C FAT1 SCAP MTMR14 XPO6 USP40 PCNX1 CACNA1H PRKDC HERC1 CRAMP1 IGSF3	4.89e-07	1105	154	19	35748872
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	NCAPD3 DYNC2H1 GAL3ST1 PEG10 TMEM135 INTS1 SPG11 APOB JAK1 FAM20C FAT1 SCAP LMAN1 LRP10 LTN1 PRKDC HERC1 RMND1	1.21e-06	1061	154	18	33845483
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PMS1 SMG1 NCAPD3 NUP85 DGKA GPAM YTHDC2 ECT2 PIK3R4 LPIN3 RECQL4 KMT2A IFT122 TASOR	1.32e-06	650	154	14	38777146
Pubmed	Loss of zinc-finger protein 212 leads to Purkinje cell death and locomotive abnormalities with phospholipase D3 downregulation.	GRID2 TTBK2 KCND3 PRKCG CACNA1G	1.89e-06	46	154	5	34815492
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	PDS5B SLITRK4 CHD9 YTHDC2 SPG11 TRIP12 PIK3R4 KMT2A MYOM2 LIMCH1 HERC1 RMND1	2.43e-06	497	154	12	36774506
Pubmed	SCAP knockout in SM22α-Cre mice induces defective angiogenesis in the placental labyrinth.	TGFBR3 SCAP PIGF CDH5	5.99e-06	27	154	4	33227706
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	DYNC2H1 TTC21A ECT2 NME8 LPIN3 XYLT2 TBC1D32 SF3B3 LMAN1 NEK5 XPO6 PI4KB SIPA1L1 PTPRQ EXOC6B LTV1 IFT122 RSPH10B WDR62	6.61e-06	1321	154	19	27173435
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NELFB CEP192 STIL ECT2 TRIP12 PIK3R4 LPIN3 ALMS1 ZFP36L1 PI4KB SIPA1L1 KMT2A PRKCG LIMCH1 WDR62	7.21e-06	861	154	15	36931259
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PDS5B NCAPD3 NELFB YTHDC2 TRIP12 PITPNM1 XPO6 SIPA1L1 ZBTB40 KMT2A LIMCH1 PRKDC TOPORS WDR62	9.72e-06	774	154	14	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TDRD15 STON1 VPS13C NELFB APOB CEP192 TRIP12 CDC42BPB FAT1 PI4KB EEF2K PRKDC TASOR IGSF3	1.01e-05	777	154	14	35844135
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	PEG10 INTS1 YTHDC2 ALMS1 XPO6 LTN1 LTV1 TASOR	1.33e-05	242	154	8	34011540
Pubmed	Protein kinase Cdelta regulates apoptosis via activation of STAT1.	STAT1 JAK1 PRKCG	1.37e-05	11	154	3	15322115
Pubmed	Analysis of mouse embryonic patterning and morphogenesis by forward genetics.	DYNC2H1 TTBK2 IFT122 DISP1	1.37e-05	33	154	4	15755804
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	NTRK1 SLITRK4 CUBN FZD9 LRFN5 PRKCG	1.43e-05	117	154	6	17145500
Pubmed	Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.	STAT1 JAK1 HCK	1.82e-05	12	154	3	10918587
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	NUP85 STAT1 XPO6 LTN1 EXOC6B PRKDC COG5	1.84e-05	183	154	7	23956138
Pubmed	Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription.	STAT1 JAK1	1.95e-05	2	154	2	7490523
Pubmed	Cav3.2 subunit underlies the functional T-type Ca2+ channel in murine hearts during the embryonic period.	CACNA1H CACNA1G	1.95e-05	2	154	2	14988077
Pubmed	Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice.	CACNA1H CACNA1G	1.95e-05	2	154	2	21622683
Pubmed	Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.	STAT1 JAK1	1.95e-05	2	154	2	8608597
Pubmed	Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain.	CACNA1H CACNA1G	1.95e-05	2	154	2	20685979
Pubmed	Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.	CACNA1H CACNA1G	1.95e-05	2	154	2	23436820
Pubmed	Deficiency of T-type Ca2+ channels Cav3.1 and Cav3.2 has no effect on angiotensin II-induced hypertension but differential effect on plasma aldosterone in mice.	CACNA1H CACNA1G	1.95e-05	2	154	2	31042060
Pubmed	Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling.	STAT1 JAK1	1.95e-05	2	154	2	17686504
Pubmed	Regulation of STAT1 nuclear export by Jak1.	STAT1 JAK1	1.95e-05	2	154	2	10982844
Pubmed	Sandfly Fever Viruses Attenuate the Type I Interferon Response by Targeting the Phosphorylation of JAK-STAT Components.	STAT1 JAK1	1.95e-05	2	154	2	35720342
Pubmed	Specificity of MLL1 and TET3 CXXC domains towards naturally occurring cytosine modifications.	KMT2A TET3	1.95e-05	2	154	2	30352306
Pubmed	T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.	CACNA1H CACNA1G	1.95e-05	2	154	2	22469755
Pubmed	Hair bundle defects and loss of function in the vestibular end organs of mice lacking the receptor-like inositol lipid phosphatase PTPRQ.	ADGRV1 PTPRQ	1.95e-05	2	154	2	22357859
Pubmed	SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1.	STAT1 JAK1	1.95e-05	2	154	2	35317858
Pubmed	Different distribution of Cav3.2 and Cav3.1 transcripts encoding T-type Ca(2+) channels in the embryonic heart of mice.	CACNA1H CACNA1G	1.95e-05	2	154	2	21079360
Pubmed	Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway.	STAT1 JAK1	1.95e-05	2	154	2	23703473
Pubmed	JAK/STAT pathway and molecular mechanism in bone remodeling.	STAT1 JAK1	1.95e-05	2	154	2	33099760
Pubmed	The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.	CACNA1H CACNA1G	1.95e-05	2	154	2	22886848
Pubmed	Deletion of T-type calcium channels Cav3.1 or Cav3.2 attenuates endothelial dysfunction in aging mice.	CACNA1H CACNA1G	1.95e-05	2	154	2	29082441
Pubmed	GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance.	SLC2A4 ALMS1	1.95e-05	2	154	2	25299671
Pubmed	Interaction between DNA-dependent protein kinase and a novel protein, KIP.	CIB1 PRKDC	1.95e-05	2	154	2	9372844
Pubmed	[Decreased mRNA expressions of T-type channel alpha1H and alpha1G in the sperm of varicocele patients and their implication].	CACNA1H CACNA1G	1.95e-05	2	154	2	22574369
Pubmed	Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation.	CACNA1H CACNA1G	1.95e-05	2	154	2	21438841
Pubmed	CD3+ T cells in severe combined immunodeficiency (scid) mice. VI. Rescue of scid-derived, IgM-producing B cells by transfer of CD4+ CD8- T cells from various lymphoid organs.	GRID2 PRKDC	1.95e-05	2	154	2	1358814
Pubmed	β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A.	CACNA1H CACNA1G	1.95e-05	2	154	2	22808078
Pubmed	Intestinal maturation in mice lacking CCAAT/enhancer-binding protein alpha (C/EPBalpha).	APOB LCT SLC2A4	2.36e-05	13	154	3	9494081
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MXRA5 VPS13C TTC21A INTS1 NELFB DGKA GPAM ECT2 TRIP12 ARHGAP5 FAM20C RECQL4 PRKDC	2.62e-05	736	154	13	29676528
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PITPNM2 VPS13C TTC21A CHD9 ANKMY1 CEP192 VPS54 ADGRV1 CDC42BPB KCND3 SFXN3 USP40 EXOC6B CACNA1H IFT122 LIMCH1 CSMD1 TET3 CRAMP1	3.46e-05	1489	154	19	28611215
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	NCAPD3 TRIP12 CDC42BPB LTN1 MROH7 PRKDC MAGEC1	3.47e-05	202	154	7	33005030
Pubmed	Large-scale screen for genes involved in gonad development.	PEG10 NTRK1 LRP10 LPIN2 TET3	4.16e-05	86	154	5	11044607
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	STON1 YTHDC2 CEP192 ALMS1 SIPA1L1 LTV1 WDR62	4.31e-05	209	154	7	36779422
Pubmed	Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.	TTBK2 KCND3 PRKCG	5.53e-05	17	154	3	15148151
Pubmed	STAT1 mediated downregulation of the tumor suppressor gene PDCD4, is driven by the atypical cadherin FAT1, in glioblastoma.	STAT1 FAT1	5.83e-05	3	154	2	38640981
Pubmed	Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene.	LPIN3 LPIN2	5.83e-05	3	154	2	10884287
Pubmed	5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.	CACNA1H CACNA1G	5.83e-05	3	154	2	24327205
Pubmed	Downregulated SOCS1 expression activates the JAK1/STAT1 pathway and promotes polarization of macrophages into M1 type.	STAT1 JAK1	5.83e-05	3	154	2	28901399
Pubmed	Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2.	LPIN3 LPIN2	5.83e-05	3	154	2	18694939
Pubmed	Progesterone activates Janus Kinase 1/2 and activators of transcription 1 (JAK1-2/STAT1) pathway in human spermatozoa.	STAT1 JAK1	5.83e-05	3	154	2	22748021
Pubmed	Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.	CACNA1H CACNA1G	5.83e-05	3	154	2	23488970
Pubmed	Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo.	CACNA1H CACNA1G	5.83e-05	3	154	2	24966091
Pubmed	Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.	STAT1 JAK1	5.83e-05	3	154	2	25589644
Pubmed	Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-γ signal transduction pathways.	STAT1 JAK1	5.83e-05	3	154	2	26901336
Pubmed	Identification of lipidomic profiles associated with drug-resistant prostate cancer cells.	LPIN3 LPIN2	5.83e-05	3	154	2	33596934
Pubmed	Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart.	CACNA1H CACNA1G	5.83e-05	3	154	2	11230107
Pubmed	Pitpnm1 is expressed in hair cells during development but is not required for hearing.	PITPNM2 PITPNM1	5.83e-05	3	154	2	23820044
Pubmed	MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway.	STAT1 JAK1	5.83e-05	3	154	2	28334721
Pubmed	Homeostatic plasticity and burst activity are mediated by hyperpolarization-activated cation currents and T-type calcium channels in neuronal cultures.	CACNA1H CACNA1G	5.83e-05	3	154	2	33547341
Pubmed	Calmodulin regulates Cav3 T-type channels at their gating brake.	CACNA1H CACNA1G	5.83e-05	3	154	2	28972185
Pubmed	DNA-protein kinase catalytic subunit-interacting protein KIP binds telomerase by interacting with human telomerase reverse transcriptase.	CIB1 PRKDC	5.83e-05	3	154	2	15190070
Pubmed	Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis.	STAT1 JAK1	5.83e-05	3	154	2	20103601
Pubmed	ZnT-1 enhances the activity and surface expression of T-type calcium channels through activation of Ras-ERK signaling.	CACNA1H CACNA1G	5.83e-05	3	154	2	22572848
Pubmed	[Functional analysis of molecules involved in synaptic plasticity in the cerebellum].	GRIA2 GRID2	5.83e-05	3	154	2	21089334
Pubmed	Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.	STAT1 JAK1	5.83e-05	3	154	2	26193702
Pubmed	Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.	KMT2A PRKDC	5.83e-05	3	154	2	18538732
Pubmed	The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling.	STAT1 JAK1	5.83e-05	3	154	2	27304884
Pubmed	RNF220 mediates K63-linked polyubiquitination of STAT1 and promotes host defense.	STAT1 JAK1	5.83e-05	3	154	2	32814877
Pubmed	Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.	TGFBR3 PRKDC	5.83e-05	3	154	2	23925295
Pubmed	T-type, but not L-type, voltage-gated calcium channels are dispensable for lymphatic pacemaking and spontaneous contractions.	CACNA1H CACNA1G	5.83e-05	3	154	2	31919478
Pubmed	Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice.	CACNA1H CACNA1G	5.83e-05	3	154	2	11897840
Pubmed	Target neuron controls the integrity of afferent axon phenotype: a study on the Purkinje cell-climbing fiber system in cerebellar mutant mice.	GRID2 HERC1	5.83e-05	3	154	2	7891151
Pubmed	Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).	STAT1 JAK1	5.83e-05	3	154	2	21383241
Pubmed	The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.	STAT1 JAK1	5.83e-05	3	154	2	8232552
Pubmed	Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance.	KMT2A PRKDC	5.83e-05	3	154	2	32763164
Pubmed	A novel viral SOCS from infectious spleen and kidney necrosis virus: interacts with Jak1 and inhibits IFN-α induced Stat1/3 activation.	STAT1 JAK1	5.83e-05	3	154	2	22844427
Pubmed	Cloning and characterization of a novel variant (mM-rdgBbeta1) of mouse M-rdgBs, mammalian homologs of Drosophila retinal degeneration B gene proteins, and its mRNA localization in mouse brain in comparison with other M-rdgBs.	PITPNM2 PITPNM1	5.83e-05	3	154	2	12562526
Pubmed	Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation.	SPG11 PI4KB	5.83e-05	3	154	2	25365221
Pubmed	Lipin 2/3 phosphatidic acid phosphatases maintain phospholipid homeostasis to regulate chylomicron synthesis.	LPIN3 LPIN2	5.83e-05	3	154	2	30507612
Pubmed	T-type channels: release a brake, engage a gear.	CACNA1H CACNA1G	5.83e-05	3	154	2	26488564
Pubmed	JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts.	STAT1 JAK1	5.83e-05	3	154	2	17908914
Pubmed	Lipin proteins form homo- and hetero-oligomers.	LPIN3 LPIN2	5.83e-05	3	154	2	20735359
Pubmed	Differential interactions of Na+ channel toxins with T-type Ca2+ channels.	CACNA1H CACNA1G	5.83e-05	3	154	2	18591418
Pubmed	Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.	CACNA1H CACNA1G	5.83e-05	3	154	2	28846697
Pubmed	Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels.	CACNA1H CACNA1G	5.83e-05	3	154	2	21084288
Pubmed	Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia.	LPIN3 LPIN2	5.83e-05	3	154	2	22481384
Pubmed	SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.	STAT1 JAK1	5.83e-05	3	154	2	34228987
Pubmed	Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability.	CACNA1H CACNA1G	5.83e-05	3	154	2	11927664
Pubmed	Aloin suppresses lipopolysaccharide‑induced inflammation by inhibiting JAK1‑STAT1/3 activation and ROS production in RAW264.7 cells.	STAT1 JAK1	5.83e-05	3	154	2	30066904
Pubmed	Macrophage neogenin deficiency exacerbates myocardial remodeling and inflammation after acute myocardial infarction through JAK1-STAT1 signaling.	STAT1 JAK1	5.83e-05	3	154	2	37824022
Pubmed	Lipin-1 and lipin-3 together determine adiposity in vivo.	LPIN3 LPIN2	5.83e-05	3	154	2	24634820
Pubmed	Chromosomal localization, genomic organization and evolution of the genes encoding human phosphatidylinositol transfer protein membrane-associated (PITPNM) 1, 2 and 3.	PITPNM2 PITPNM1	5.83e-05	3	154	2	15627748
Interaction	C3orf18 interactions	PDS5B SMG1 NCAPD3 DYNC2H1 INTS1 STAT1 XPO6 LTN1 EXOC6B PRKDC	1.38e-08	115	149	10	int:C3orf18
Interaction	BBS7 interactions	PMS1 TTC21A STIL MTMR6 ALMS1 CDC123 MTO1 TASOR	2.20e-07	85	149	8	int:BBS7
Interaction	NPTN interactions	PDS5B SMG1 NUP85 DYNC2H1 INTS1 SPG11 CDC123 XPO6 SFXN3 LTN1 SFXN2 COG5	1.11e-06	278	149	12	int:NPTN
Interaction	TRIM66 interactions	CUL9 YTHDC2 JAK1 FAT1 ALMS1 SIPA1L1 LTN1 SFXN2 CSMD1 WDR62	3.05e-06	205	149	10	int:TRIM66
Interaction	GPR17 interactions	PDS5B INTS1 SPG11 PIK3R4 XYLT2 LRP10 XPO6 LTN1 PRKDC RMND1 COG5	8.58e-06	283	149	11	int:GPR17
Interaction	DNAJC10 interactions	NTRK1 ECT2 FAM20C LMAN1 ERAP2 CDC123 PI4KB RECQL4 PRKCG ARRDC3	2.44e-05	260	149	10	int:DNAJC10
Interaction	OC90 interactions	GNPTAB STIL ALMS1 RECQL4	2.72e-05	24	149	4	int:OC90
Interaction	GPR182 interactions	PDS5B NCAPD3 INTS1 SPG11 PIK3R4 JAK1 LRP10 XPO6 SFXN3 LTN1 SFXN2 PRKDC COG5	3.45e-05	455	149	13	int:GPR182
Interaction	CDC42 interactions	PMS1 PDS5B ABCC1 NCAPD3 NUP85 DYNC2H1 SLITRK4 SH3GLB2 GRIA2 ECT2 CDC42BPB STAT1 JAK1 ARHGAP5 FAT1 LMAN1 LRP10 CDC123 RECQL4 SFXN3 PRKCG PRKDC COG5 IGSF3	3.88e-05	1323	149	24	int:CDC42
Interaction	C19orf38 interactions	PDS5B NCAPD3 NUP85 DYNC2H1 LTN1 PRKDC	4.27e-05	86	149	6	int:C19orf38
Interaction	OR2T12 interactions	OR2T33 OR2T12	5.43e-05	2	149	2	int:OR2T12
Interaction	CRYL1 interactions	DYNC2H1 SPG11 STIL ALMS1 IFT122	5.82e-05	56	149	5	int:CRYL1
Interaction	LPIN1 interactions	NTRK1 LPIN3 LPIN2 ARRDC3	7.73e-05	31	149	4	int:LPIN1
Interaction	DNAJC7 interactions	DYNC2H1 VPS13C PEG10 NTRK1 SPG11 LMAN1 CDC123 RECQL4 IFT122 PRKDC MTO1 WDR62	7.80e-05	425	149	12	int:DNAJC7
GeneFamily	Lipins	LPIN3 LPIN2	8.87e-05	3	99	2	1043
GeneFamily	Sideroflexins	SFXN3 SFXN2	2.94e-04	5	99	2	746
GeneFamily	Phosphatidylinositol transfer proteins	PITPNM2 PITPNM1	4.39e-04	6	99	2	1151
GeneFamily	Immunoglobulin like domain containing	A1BG MXRA5 NTRK1 SLAMF6 MYOM2 IGSF3	6.74e-04	193	99	6	594
GeneFamily	Zinc fingers CXXC-type	KMT2A TET3	1.89e-03	12	99	2	136
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR6 MTMR14	2.98e-03	15	99	2	903
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	PDS5B SMG1 VPS13C GNPTAB SH2D3C DGKA YTHDC2 SPG11 TRIP12 ITGB7 STAT1 JAK1 TGFBR3 SLAMF6 SF3B3 ZFP36L1 ERAP2 XPO6 LPIN2 KMT2A PCNX1 HERC1 TASOR NLRC3 HECA	1.61e-06	1492	152	25	M40023
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	NUP85 TMEM135 SH3GLB2 CHD9 STAT1 LRP10 KMT2A HCK	2.21e-05	199	152	8	M9964
Coexpression	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP	INTS1 PITPNM1 JAK1 SCAP XPO6 SIPA1L1 PCNX1 PRKDC	2.29e-05	200	152	8	M6090
Coexpression	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP	ABCC1 CCDC90B CHD9 SPG11 PIK3R4 XYLT2 MTMR14 WDR62	2.29e-05	200	152	8	M6618
ToppCell	CV\|World / Virus stimulation, Condition and Cluster	GNPTAB ITGB7 STAT1 JAK1 TGFBR3 LRP10 ZFP36L1 ERAP2	4.83e-07	198	155	8	6a28193af35abec5c029129930c2ca6febaafde2
ToppCell	CD8+_Memory_T_cell-CV\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	GNPTAB ITGB7 STAT1 JAK1 TGFBR3 LRP10 ZFP36L1 ERAP2	4.83e-07	198	155	8	3d1749f5106f0912f4a74615863853949f52c73d
ToppCell	COVID-19_Mild\|World / 5 Neutrophil clusters in COVID-19 patients	HECW1 ADGRV1 CD163 MFSD14A RSPH10B2 PCNX1 CSMD1	1.07e-06	152	155	7	2ff0980dfd8d430cca14649151d856edef115720
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	STIL RSPH10B2 ALMS1 RECQL4 DLEC1 IFT122 WDR62	1.33e-06	157	155	7	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A GRID2 CUBN FAM20C PTPRQ SFXN2 CSMD1	3.42e-06	181	155	7	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 APOB ADGRV1 FAT1 PTPRQ MYOM2 CSMD1	3.81e-06	184	155	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 APOB ADGRV1 FAT1 PTPRQ MYOM2 CSMD1	3.81e-06	184	155	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 APOB ADGRV1 FAT1 PTPRQ MYOM2 CSMD1	3.81e-06	184	155	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DYNC2H1 STIL ECT2 ALMS1 RECQL4 IFT122 WDR62	4.71e-06	190	155	7	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HECW1 GAL3ST1 SLITRK4 GRIA2 FZD9 LRFN5 CSMD1	6.37e-06	199	155	7	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HECW1 GAL3ST1 SLITRK4 GRIA2 FZD9 LRFN5 CSMD1	6.37e-06	199	155	7	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GNPTAB TMEM71 ITGB7 TGFBR3 SLAMF6 MYOM2 NLRC3	6.59e-06	200	155	7	0a6fc7eff94e2f71af9f31a01779aafd2f4a6699
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCC1 DGKA CCDC90B ARHGAP5 PCNX1 HECA	2.64e-05	167	155	6	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 VPS13C CHD9 ARHGAP5 ARRDC3 TASOR	3.55e-05	176	155	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122\|Adult / Lineage, Cell type, age group and donor	PITPNM2 ADGRV1 DUOX1 FAT1 LIMCH1 SHISA6	3.55e-05	176	155	6	3fee8a367bb9755aca1b7fcc968b08e51b6e9436
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GNPTAB TGFBR3 SLAMF6 PCNX1 MYOM2 CRAMP1	3.66e-05	177	155	6	d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GNPTAB TGFBR3 SLAMF6 PCNX1 MYOM2 CRAMP1	3.66e-05	177	155	6	f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_activated\|COVID-19_Mild / Disease group, lineage and cell class	GNPTAB TGFBR3 SLAMF6 PCNX1 MYOM2 CRAMP1	3.66e-05	177	155	6	6978a22fef40c8b455342373abe7593f5ede0fa4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	GNPTAB TGFBR3 SLAMF6 PCNX1 MYOM2 CRAMP1	3.66e-05	177	155	6	936ab2b180a052387124f68d0c7f41c0b164e748
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GNPTAB TGFBR3 SLAMF6 PCNX1 MYOM2 CRAMP1	3.66e-05	177	155	6	d5aeda113afaa2425874394610344570c9078478
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_C\|356C / Donor, Lineage, Cell class and subclass (all cells)	GNPTAB ITGB7 JAK1 TGFBR3 MYOM2 NLRC3	3.78e-05	178	155	6	7203149864cc8d5ae25329fdbf15c6b73c3d3595
ToppCell	severe-Myeloid-Eosinophils\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ABCC1 STON1 NTRK1 ITGB7 EEF2K NLRC3	4.02e-05	180	155	6	ac03812b1409435c55d323a7516deeac82bd3509
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	R3HCC1 NME8 TGFBR3 SLAMF6 MYOM2 NLRC3	4.15e-05	181	155	6	5cecbafc29cc95896e6ccb2c74d9237b9aaece69
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DGKA JAK1 XYLT2 MTMR6 LRP10 XPO6	4.69e-05	185	155	6	a2cae8c657e4f4d121476798e424876f7e247973
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DGKA JAK1 XYLT2 MTMR6 LRP10 XPO6	4.69e-05	185	155	6	d50406a9a5b8d75110ba5985741aa2293950c543
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VPS13C ADGRV1 ZFP36L1 KDM7A CSMD1 TET3	4.83e-05	186	155	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte-7\|World / Primary Cells by Cluster	PRSS35 CIB1 ADGRV1 ARHGAP5 LRP10 ZFP36L1	5.43e-05	190	155	6	8f1c490dd8e5f80382f5294fd1aa8cba4c3c647f
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRSS35 DENND2A FAT1 CACNA1H MYOM2 CSMD1	5.43e-05	190	155	6	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte\|World / Primary Cells by Cluster	PRSS35 CIB1 ADGRV1 ARHGAP5 LRP10 ZFP36L1	5.43e-05	190	155	6	7dbfd543398c63cbe1e68b54bcb5e2291f521935
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PDS5B NCAPD3 CEP192 STIL ECT2 WDR62	5.43e-05	190	155	6	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DGKA TMEM71 SLAMF6 PCNX1 NLRC3 HECA	5.59e-05	191	155	6	d9506b88d806aadd4c2b9bf86fe994c47799e7f6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DGKA TMEM71 SLAMF6 PCNX1 NLRC3 HECA	5.59e-05	191	155	6	b42c54308abe1241cc38ddce96b9d38d07983891
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	PRSS35 DENND2A FAT1 CACNA1H MYOM2 CSMD1	5.59e-05	191	155	6	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DGKA TMEM71 SLAMF6 PCNX1 NLRC3 HECA	5.59e-05	191	155	6	9aabbc65430e2233b8f2d3fff9face7807b88b48
ToppCell	IPF-Lymphoid-NK\|World / Disease state, Lineage and Cell class	GNPTAB TMEM71 TGFBR3 SLAMF6 MYOM2 CRAMP1	5.59e-05	191	155	6	f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DYNC2H1 TTC21A ADGRV1 RSPH10B2 NEK5 DLEC1	5.93e-05	193	155	6	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 DGKA TBC1D32 RSPH10B2 GARIN1B HERC1	5.93e-05	193	155	6	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	COPD-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	GNPTAB TMEM71 JAK1 TGFBR3 MYOM2 CRAMP1	5.93e-05	193	155	6	0020249fa71afb500af73700543bb6f349be6b10
ToppCell	Int-URO-Lymphocyte-T_NK-NK\|Int-URO / Disease, Lineage and Cell Type	GNPTAB JAK1 TGFBR3 SLAMF6 MYOM2 NLRC3	5.93e-05	193	155	6	5c7942f630fc69374df34ee3602ad973b6ced17a
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	STIL PITPNM1 ALMS1 RECQL4 IFT122 WDR62	6.10e-05	194	155	6	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	Mild-CD8+_T\|World / Disease group and Cell class	SH2D3C ITGB7 ZFP36L1 KMT2A HERC1 NLRC3	6.10e-05	194	155	6	d64c2efb482bcdef9240977eae1023c4191286e7
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NCAPD3 GNPTAB ITGB7 NEK5 RMND1 NLRC3	6.27e-05	195	155	6	83c125223e7ca0f08a31414b3a16347912564765
ToppCell	T_cells-CTLs\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	GNPTAB SPG11 ITGB7 B4GALT5 TGFBR3 SLAMF6	6.64e-05	197	155	6	28117cf300e169182571fbad0de1681a484a435a
ToppCell	mild-dn_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HECW1 TMEM135 DGKA STAT1 SLAMF6 ZBTB40	6.64e-05	197	155	6	07a1f59c83b748825e0708cd1cc7b63a2cb856cc
ToppCell	COVID_vent-Lymphocytic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DGKA ITGB7 TGFBR3 SLAMF6 LMAN1 KMT2A	6.83e-05	198	155	6	ee80f647317377081b4bd194ee2801f556b3a53b
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	PEG10 SLITRK4 SH2D3C GRIA2 SFXN3 IGSF3	6.83e-05	198	155	6	4e598aab92141e7d32ec963291ddeed14a21beba
ToppCell	Severe-B_intermediate-10\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CIB1 VPS13C TMEM71 FAM20C MYOM2 HCK	6.83e-05	198	155	6	dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	DGKA ITGB7 JAK1 TGFBR3 SLAMF6 KMT2A	7.02e-05	199	155	6	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DYNC2H1 GRID2 FZD9 TGFBR3 LRFN5 RECQL4	7.02e-05	199	155	6	abd6117f8a3d7e798d8471c16d97b34aaf50fc9c
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GNPTAB TMEM71 ITGB7 TGFBR3 SLAMF6 NLRC3	7.22e-05	200	155	6	0b65855617fb7730de48facf411e2a8980f9f780
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	B4GALT5 LRP10 XPO6 PCNX1 ZDHHC19 HCK	7.22e-05	200	155	6	6beabd5bad042d4d65c89c2f537c7376230f7c08
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GNPTAB TMEM71 ITGB7 TGFBR3 SLAMF6 NLRC3	7.22e-05	200	155	6	4150170a135c37a7932bfb61acedac22dad01a3e
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GNPTAB TMEM71 ITGB7 SLAMF6 MYOM2 NLRC3	7.22e-05	200	155	6	d1cfc4ef6ae75c486427e393d98b84a2a7ec67fe
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	B4GALT5 LRP10 XPO6 PCNX1 ZDHHC19 HCK	7.22e-05	200	155	6	026495aa7f1e7528a01d9199475cfc393677fc60
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-6\|TCGA-Thryoid / Sample_Type by Project: Shred V9	GPAM NME8 SLC2A4 DUOX1 CSMD1	1.10e-04	135	155	5	8197d49e697a1fdcd64040ea7a7f0b3ad0a756eb
ToppCell	LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTRK1 GNPTAB NME8 NLRC3 SHISA6	1.14e-04	136	155	5	82d7f90ef2a63a3137c331efd68c036cd0db3ac1
Disease	Spinocerebellar Ataxia Type 2	GRID2 TTBK2 PRKCG CACNA1G	2.44e-05	34	147	4	C0752121
Disease	Spinocerebellar Ataxia Type 1	GRID2 TTBK2 PRKCG CACNA1G	2.44e-05	34	147	4	C0752120
Disease	Spinocerebellar Ataxia Type 5	GRID2 TTBK2 PRKCG CACNA1G	2.44e-05	34	147	4	C0752123
Disease	Spinocerebellar Ataxia Type 7	GRID2 TTBK2 PRKCG CACNA1G	2.44e-05	34	147	4	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	GRID2 TTBK2 PRKCG CACNA1G	2.44e-05	34	147	4	C0752124
Disease	Ataxia, Spinocerebellar	GRID2 TTBK2 PRKCG CACNA1G	2.44e-05	34	147	4	C0087012
Disease	Spinocerebellar Ataxia Type 4	GRID2 TTBK2 PRKCG CACNA1G	2.75e-05	35	147	4	C0752122
Disease	Inherited neuropathies	NTRK1 SPG11 TTBK2 PRKCG	4.70e-05	40	147	4	C0598589
Disease	myoglobinuria (implicated_via_orthology)	LPIN3 LPIN2	7.37e-05	3	147	2	DOID:0080108 (implicated_via_orthology)
Disease	electrocardiography	STON1 TMEM135 YTHDC2 KCND3 CDC123 SIPA1L1 USP40 PCNX1 CACNA1G COG5 HCK	7.45e-05	530	147	11	EFO_0004327
Disease	Adenocarcinoma of large intestine	PMS1 NTRK1 CDC42BPB EEF2K PRKDC	1.22e-04	96	147	5	C1319315
Disease	Autosomal Recessive Primary Microcephaly	NCAPD3 STIL WDR62	1.74e-04	22	147	3	C3711387
Disease	sensory peripheral neuropathy, remission	KMT2A DLEC1 CSMD1	1.99e-04	23	147	3	EFO_0009785, MONDO_0002321
Disease	post-operative atrial fibrillation, response to surgery	STON1 ADGRV1	2.44e-04	5	147	2	EFO_0009951, EFO_0009952
Disease	TEMPS-A questionnaire	DYNC2H1 CSMD1 SHISA6	2.57e-04	25	147	3	EFO_0004783
Disease	level of Sterol ester (27:1/18:2) in blood serum	TDRD15 APOB NKPD1	2.90e-04	26	147	3	OBA_2045194
Disease	apolipoprotein A 1 measurement	PITPNM2 STON1 GPAM SPG11 APOB CD163 ZFP36L1 XPO6 LPIN2 KMT2A DLEC1 HERC1 COG5	3.37e-04	848	147	13	EFO_0004614
Disease	VACTERL association (implicated_via_orthology)	DYNC2H1 TBC1D32	3.65e-04	6	147	2	DOID:14679 (implicated_via_orthology)
Disease	resting heart rate, chronic obstructive pulmonary disease	STON1 ADGRV1 HERC1	4.46e-04	30	147	3	EFO_0000341, EFO_0004351
Disease	Disproportionate short stature	DYNC2H1 FAM20C IFT122 IHH	6.03e-04	77	147	4	C0878659
Disease	Profound Mental Retardation	TMEM135 ZBTB40 PRKCG CACNA1G WDR62	6.75e-04	139	147	5	C0020796
Disease	Mental Retardation, Psychosocial	TMEM135 ZBTB40 PRKCG CACNA1G WDR62	6.75e-04	139	147	5	C0025363
Disease	Mental deficiency	TMEM135 ZBTB40 PRKCG CACNA1G WDR62	6.75e-04	139	147	5	C0917816
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 APOB	6.77e-04	8	147	2	EFO_0008589, EFO_0008595
Disease	2-aminooctanoate measurement	ALMS1 TMEM266	6.77e-04	8	147	2	EFO_0800349
Disease	QRS duration	PDS5B KCND3 SIPA1L1 KMT2A DLEC1 MYOM2 COG5	7.63e-04	298	147	7	EFO_0005055
Disease	primary bacterial infectious disease (implicated_via_orthology)	DUOX1 IHH	8.67e-04	9	147	2	DOID:0050338 (implicated_via_orthology)
Disease	2-ketocaprylate measurement	ALMS1 TMEM266	1.08e-03	10	147	2	EFO_0800110
Disease	Combined immunodeficiency	STAT1 RECQL4 PRKDC	1.12e-03	41	147	3	C0494261
Disease	kidney disease (implicated_via_orthology)	CUBN LCT HCK	1.12e-03	41	147	3	DOID:557 (implicated_via_orthology)
Disease	dimethylglycine measurement	SFXN2 TMEM266 CACNA1G	1.57e-03	46	147	3	EFO_0010476
Disease	N-acetyl-2-aminooctanoate measurement	ALMS1 TMEM266	1.57e-03	12	147	2	EFO_0800567
Disease	Hypermetropia	DGKA ALMS1 TMEM266 SHISA6	1.78e-03	103	147	4	HP_0000540
Disease	lipoprotein measurement	TDRD15 GPAM APOB TASOR	1.91e-03	105	147	4	EFO_0004732
Disease	thalamus volume change measurement	FAT1 LRFN5	2.16e-03	14	147	2	EFO_0021496
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 APOB	2.16e-03	14	147	2	EFO_0004611, EFO_0008589
Disease	lower face morphology measurement	YTHDC2 KCND3 ZBTB40 MYOM2	2.19e-03	109	147	4	EFO_0010948
Disease	total phospholipids in lipoprotein particles measurement	TDRD15 GPAM APOB	2.36e-03	53	147	3	EFO_0022315
Disease	low density lipoprotein triglyceride measurement	TDRD15 APOB	2.48e-03	15	147	2	EFO_0009946
Disease	Opioid use measurement	KCND3 MYOM2	2.48e-03	15	147	2	EFO_0009937
Disease	Autosomal recessive primary microcephaly	STIL WDR62	2.48e-03	15	147	2	cv:C3711387
Disease	response to statin, LDL cholesterol change measurement	TDRD15 APOB	2.48e-03	15	147	2	EFO_0007804, GO_0036273
Disease	lipid metabolism disorder (implicated_via_orthology)	LPIN3 LPIN2	2.48e-03	15	147	2	DOID:3146 (implicated_via_orthology)
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	TDRD15 GPAM APOB ECT2 FZD9 SIPA1L1	2.58e-03	274	147	6	EFO_0004530, EFO_0004612
Disease	macula measurement	PITPNM2 STON1 FAT1 LIMCH1 COG5	2.62e-03	189	147	5	EFO_0008375
Disease	sleep apnea measurement	HECW1 DLEC1 LIMCH1 IHH	2.75e-03	116	147	4	EFO_0007817
Disease	free cholesterol to total lipids in large HDL percentage	TDRD15 GPAM APOB	2.77e-03	56	147	3	EFO_0022279
Disease	primary autosomal recessive microcephaly (is_implicated_in)	NCAPD3 WDR62	2.83e-03	16	147	2	DOID:0070296 (is_implicated_in)
Disease	Malignant neoplasm of breast	ABCC1 DYNC2H1 CUBN ECT2 NME8 STAT1 PIK3R4 SIPA1L1 MROH7 DLEC1 ARRDC3 RMND1 CDH5	2.85e-03	1074	147	13	C0006142
Disease	cholesterol in IDL measurement	TDRD15 GPAM APOB	3.06e-03	58	147	3	EFO_0021899
Disease	glutarylcarnitine (C5-DC) measurement	ABCC1 TMEM266	3.19e-03	17	147	2	EFO_0800030
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	TDRD15 APOB	3.19e-03	17	147	2	EFO_0022232
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	TDRD15 GPAM SPG11 APOB	3.20e-03	121	147	4	EFO_0008595, EFO_0020943
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	TDRD15 GPAM SPG11 APOB FZD9	3.34e-03	200	147	5	EFO_0004611, EFO_0020945
Disease	total lipids in IDL	TDRD15 GPAM APOB	3.37e-03	60	147	3	EFO_0022161
Disease	basophil measurement	ABCC1 VPS54 HECA	3.37e-03	60	147	3	EFO_0803539
Disease	PR interval	CUL9 FAT1 KCND3 SIPA1L1 LPIN2 ZBTB40 CACNA1G DLEC1	3.47e-03	495	147	8	EFO_0004462
Disease	free cholesterol in IDL measurement	TDRD15 GPAM APOB	3.53e-03	61	147	3	EFO_0022181
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	JAK1 KMT2A HCK	3.53e-03	61	147	3	C1961102
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	GPAM SPG11 APOB	3.53e-03	61	147	3	EFO_0008317, EFO_0008596, EFO_0020946
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	TDRD15 APOB	3.58e-03	18	147	2	EFO_0008317, EFO_0008589
Disease	acylcarnitine measurement	ABCC1 GPAM FZD9 HERC1	3.80e-03	127	147	4	EFO_0005059
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	TDRD15 DYNC2H1 APOB	3.87e-03	63	147	3	EFO_0001645, EFO_0004792
Disease	colorectal cancer, inflammatory bowel disease	PTCHD3 ALMS1	3.99e-03	19	147	2	EFO_0003767, MONDO_0005575
Disease	Liver carcinoma	ECT2 STAT1 CD163 SCAP KMT2A CSMD1 NLRC3 WDR62	4.01e-03	507	147	8	C2239176
Disease	total lipids in very large HDL measurement	TDRD15 GPAM APOB	4.41e-03	66	147	3	EFO_0022312
Disease	urinary microalbumin measurement	YTHDC2 CUBN	4.42e-03	20	147	2	EFO_0010967
Disease	uridine diphosphate measurement	PTCHD3 YTHDC2	4.42e-03	20	147	2	EFO_0010545
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	GPAM SPG11 APOB	4.60e-03	67	147	3	EFO_0008595, EFO_0020946
Disease	radiation-induced disorder	NOX3 GRID2 DLEC1	4.60e-03	67	147	3	EFO_0009565
Disease	common carotid intimal medial thickness	TDRD15 APOB DLEC1	4.60e-03	67	147	3	EFO_0004860
Disease	Infiltrating duct carcinoma of female breast	SMG1 CDC42BPB	4.86e-03	21	147	2	C3165106

Protein segments in the cluster

Peptide	Gene	Start	Entry
RDLPFVTHTLSSEFT	CASTOR3	141	Q8NAP1
TDLVSSHELSPFRAL	AGPAT4-IT1	161	Q9H0P7
SALPEDIHSTFNSLT	CSMD1	1351	Q96PZ7
ESYFLSRENHIPTLS	TBC1D32	261	Q96NH3
LSFNNSEHFFLREPT	ADGRV1	3076	Q8WXG9
DSLFHQSELSFAPLR	ALMS1	241	Q8TCU4
SDLASSRFSVSQHPL	ALMS1	286	Q8TCU4
TLQESLQFHRPDFIS	ALMS1	4036	Q8TCU4
DLPFVTHTLSSEFTI	CASTOR2	131	A6NHX0
HSETFLQTTTFLPED	B4GALT5	91	O43286
HFSPALRREFFTTTT	CCDC90B	26	Q9GZT6
FTHRLFNASVPESSA	CDH5	151	P33151
SLELSEFQVFRSSHP	DISP1	746	Q96F81
FTVFEHIDINTPSLL	ARRDC3	156	Q96B67
TFVAFTHLLLDALPS	C17orf113	396	A0A1B0GUU1
THRDSAFIFLSQSLE	MROH7	1191	Q68CQ1
LIHRTAENFDLLSSF	R3HCC1	51	Q9Y3T6
PISFHSAETFESLLA	PDS5B	661	Q9NTI5
SLVSLPSFFERRSHT	ECT2	891	Q9H8V3
PSHRDISLAFFEAAS	JAK1	626	P23458
TLSRNTISFITPHAF	LRFN5	81	Q96NI6
TISFITPHAFADLRN	LRFN5	86	Q96NI6
EQHLRFLSTLLDSFS	LTN1	611	O94822
STSPDRIFFHLNAVA	A1BG	256	P04217
VTSFQPLLFTEAHRE	DUOX1	1006	Q9NRD9
IHSPFTTILLRTFLN	RSPH10B	481	P0C881
IHSPFTTILLRTFLN	RSPH10B2	481	B2RC85
HTIAIRFANLTPEEF	FAT1	3641	Q14517
LSDNHLPDTFFLTGI	OR52D1	6	Q9H346
SPSSLFSALHREVIE	LPIN3	721	Q9BQK8
FHFTPRLSRLNLSFN	NTRK1	111	P04629
TTPDFILLGLFNHTR	OR2T12	6	Q8NG77
RAFENPHTSTLALVF	KCND3	171	Q9UK17
FDTSRFHPQDLSRSQ	KDM7A	811	Q6ZMT4
FSVHRPETLFNISRF	IFT122	966	Q9HBG6
PESSRLLRSLTHFSN	LRP10	256	Q7Z4F1
LESVLSHLEDFFART	MAD2L1BP	131	Q15013
LSLFQSSPERTHSTF	MAGEC1	316	O60732
LSLFQSSPERTHSTF	MAGEC1	386	O60732
LSLFQSSPERTHSTF	MAGEC1	456	O60732
LIPSSTFSAHNRREE	LTV1	81	Q96GA3
FSLVLPLTFRDLNTH	NLRC3	171	Q7RTR2
QDVFRNLSHLPTFSS	GNPTAB	371	Q3T906
VRSPHLEELLTAFFS	INTS1	1551	Q8N201
HFDTPVQFLRRLDLS	HECA	336	Q9UBI9
ESHRFTVLEPNTVSF	MTMR6	476	Q9Y217
QERAVLHTDSSLPFS	MTMR14	566	Q8NCE2
FDQISAAFHRTPSLL	SLC2A4	476	P14672
TPSLETHLVQRLFFA	MTO1	416	Q9Y2Z2
LQFRFEITSSIHPDD	HECW1	336	Q76N89
FVDHNSRATTFIDPR	HECW1	1036	Q76N89
VDLEESTFSHLRSFL	HERC1	751	Q15751
FSTSEFRLTPHIDNL	GRIA2	51	P42262
DFRNTHITTTTFIPE	GRID2	921	O43424
HLSRQSSDPSVLFSL	PCNX1	1211	Q96RV3
ERYLQDSTFATSPHL	NUP85	266	Q9BW27
FRFHDPSSELAFTLE	MINDY4B	126	A8MYZ0
PGFSRELHSLISQLF	NEK5	226	Q6P3R8
VPRHLSLALFQSFET	DGKA	66	P23743
HREVLSFDVTQSPFF	PEG10	426	Q86TG7
LFSTELSVLHNFFSP	NELFB	176	Q8WX92
DHDVLSFLTFQLTEP	LMAN1	256	P49257
SELQHLATSRLPSFT	LCT	1176	P09848
FLTQLHSTFQTPDRL	PRKCG	416	P05129
IAFLRSTFAVFTHLP	EXOC6B	646	Q9Y2D4
NTAPLAHDLTFRTSS	CDC42BPB	956	Q9Y5S2
TTPDFILLGLFNHTR	OR2T33	6	Q8NG76
AFLSSLHASVLRTEP	PITPNM2	681	Q9BZ72
RVVHSPEFNLFLDSV	GARIN1B	61	Q96KD3
LFIPEHTNLSLRSSS	MFSD14A	446	Q96MC6
SRLLVFTSDDTFHTA	ITGB7	281	P26010
PEKLRAFNISTHSFS	PTPRQ	11	Q9UMZ3
SFRPLLFQASEHVAS	COG5	731	Q9UP83
TITLTFSDFDIEPHT	CUBN	2726	O60494
TVLRDPARLFESSFH	GAL3ST1	161	Q99999
TAFTVLTFLLEPHRF	FZD9	246	O00144
HFRLEEPNFSLASSI	DYNC2H1	1106	Q8NCM8
TILNTFHIPSFTIDF	APOB	2651	P04114
LDRQFTSHLVTRPSD	CHD9	436	Q3L8U1
SPRSTFSTLQELVDH	HCK	211	P08631
RTTFRLTIFHLQPSD	IGSF3	226	O75054
ESHRTSAQALFPFEA	DACT2	581	Q5SW24
DPHSAERIFLTLSNY	CACNA1G	1301	O43497
FSLEHPTDRQLFDTI	CACNA1G	1921	O43497
SSDFITRDFTQPFIH	CDC123	136	O75794
SRLEHVDFESLFSSL	DENND2A	736	Q9ULE3
VDFESLFSSLSVRHL	DENND2A	741	Q9ULE3
HTLRILQDFSSDPSS	FAM20C	86	Q8IXL6
LFSPSKEAELTFRQH	CRAMP1	846	Q96RY5
HVDRLFSQPSSQTAF	FSCN3	201	Q9NQT6
FSSFITHSPARISLS	ANKMY1	121	Q9P2S6
NSFITHSLKFLSPRE	CEP192	2466	Q8TEP8
FVHPNLTSLDFVASE	ERAP2	81	Q6P179
RFTPSEAHSRIFESV	KMT2A	701	Q03164
EAHSRIFESVTLPSN	KMT2A	706	Q03164
SLSTSEELQRQFHLF	CUL9	1636	Q8IWT3
IRLTPQAFSHFTFER	EEF2K	251	O00418
DFRRHFVNLSPFTIT	CD163	16	Q86VB7
VVALPSDFFLRIDSH	CACNA1H	1221	O95180
FILSFSPHELRDFHS	DLEC1	696	Q9Y238
FFSLETHTALSPLQF	SCAP	1031	Q12770
LSFSLLVPSETNFLH	RYK	96	P34925
DHSFTSLSTPERSFI	PMS1	246	P54277
LLFTADNHTEPAARF	IHH	276	Q14623
HFTSLSRQLEFEATS	PTCHD3	366	Q3KNS1
LERSHSTEPNLSSFL	LIMCH1	466	Q9UPQ0
TATTHASLIFSLPFR	OR10P1	156	Q8NGE3
VSRSPVYSHFNETLL	ABCC1	1146	P33527
SLLHVFSTEFRAQPL	RPUSD2	161	Q8IZ73
PDNIFRFASLTHLDI	SLITRK4	171	Q8IW52
HFFTVTDPRNLLLSG	SFXN3	26	Q9BWM7
HFLNITDPRTVFVSE	SFXN2	26	Q96NB2
SFATIRFHDLLSQLD	STAT1	51	P42224
SSDHSETRLLQEVFF	TMEM71	221	Q6P5X7
LFNETSLAFIVPHET	SLAMF6	56	Q96DU3
STLITFLDPVFAEHL	TBC1D21	211	Q8IYX1
FLPTFLDVDLTISHI	TDRD15	6	B5MCY1
TLLSDSHAPFIFILV	NKPD1	256	Q17RQ9
IPSLFLENFSILETH	PIGF	26	Q07326
VLVEFSELAFHLRSP	RECQL4	1026	O94761
ITHTSRNDEFFITPS	GPAM	546	Q9HCL2
PLLFTFVLATEHTRT	PTCHD4	731	Q6ZW05
TFHPQDFSDVISFIL	SMG1	856	Q96Q15
HFFTSRASLLDQALP	SIPA1L1	1596	O43166
DFIHTASISFLTPLR	SH3GLB2	131	Q9NR46
PEQSLSRAISHTDVF	SHISA6	416	Q6ZSJ9
HRINLSSDFLITPDF	RMND1	361	Q9NWS8
TEFIDDQTFLPHRST	ARHGAP5	96	Q13017
IHIDFGFILSSSPRN	PI4KB	686	Q9UBF8
TSAPQEDFFSVHIRA	NOX3	341	Q9HBY0
HALFLFQEPRSIVTS	TASOR	491	Q9UK61
SEFQHVISRSPDFAS	CIB1	171	Q99828
SLFFRFVSTLIDSHP	NCAPD3	1016	P42695
DRITPYLLHFSNDSV	PIK3R4	416	Q99570
IPEAQTFFRIDSHSA	SPG11	701	Q96JI7
LSSAFEAVTRIHFPE	PITPNM1	456	O00562
DPFSLLHINTDRSTV	STIL	1091	Q15468
LSADRPRLQHSFSFA	ZFP36L1	191	Q07352
SLETAEREIQHFFPL	NME8	436	Q8N427
DLNTFLHEPFSSVAI	RNASE8	66	Q8TDE3
EENASSFVPHTLFRS	STON1	256	Q9Y6Q2
RIVSERTFHLTSPAF	PRSS35	36	Q8N3Z0
HLSRSAEDSFLSPII	TTBK2	1031	Q6IQ55
SAFRHLFTQPSRLLS	TMEM135	276	Q86UB9
SRQESSFFTLTIVPH	VPS13C	2481	Q709C8
RSLFLEQVHDTSFPA	TET3	536	O43151
LLREFYPHSDSSQTQ	TTC21A	1111	Q8NDW8
QSRFHLTPLSYETLE	SF3B3	726	Q15393
STSPEAFLALRSHFA	PRKDC	3891	P78527
SEAEDHFFNPRLSIS	WDR62	1081	O43379
HFFNPRLSISTQFLS	WDR62	1086	O43379
FPSSLTSTERAFIHR	YTHDC2	66	Q9H6S0
FVSDLRPFLLNRTEH	TOPORS	336	Q9NS56
LIFLVRTTHLPFSTD	ZDHHC19	176	Q8WVZ1
SASISRQSHLEPDTF	SH2D3C	36	Q8N5H7
ITPSLLTTIFHFARF	XPO6	266	Q96QU8
EFHFVADSLPLLTQR	TRIP12	596	Q14669
LQTLHFTPEFREALF	USP40	56	Q9NVE5
LLPAESFFHTVLENS	XYLT2	431	Q9H1B5
SAQTSPELEHRVSLF	TMEM266	471	Q2M3C6
NFSLTAETEERNFPH	TGFBR3	141	Q03167
DAFFRAVTTPEHATL	ZBTB40	561	Q9NUA8
AEFSTYSHSDLNRPL	VPS54	356	Q9P1Q0
SPSSLFSAFHREVIE	LPIN2	766	Q92539
EFLSSLTVSTPFHQE	MXRA5	1421	Q9NR99
HSAFLFVRDADPLVT	MYOM2	366	P54296